Skip to main content
Journal of the International AIDS Society logoLink to Journal of the International AIDS Society
letter
. 2021 Jan 26;24(1):e25661. doi: 10.1002/jia2.25661

Inclusion as illusion: erasing transgender women in research with MSM

Tonia C Poteat 1,, L Leigh Ann van der Merwe 2, Jae Sevelius 3, JoAnne Keatley 4
PMCID: PMC7836207  PMID: 33496381

We were excited to the see the publication of the JIAS Supplement entitled, “Engagement of African men and transgender women who have sex with men in HIV research.” We agree with the supplement editors that attention to these populations are long overdue [1]. The title of the supplement suggested that African transgender women would be highlighted in this special issue; and we were eager to read studies about this highly under‐served and under‐studied population. However, as we read each article, we were deeply disappointed to find that none of them focused exclusively or even primarily on transgender women.

For many years, transgender women have advocated to have their issues explored and understood separately from men who have sex with men (MSM) and other key populations. Transgender women’s social contexts are distinct from MSM. They face unique challenges when accessing HIV prevention and treatment, and meetings their needs requires focused research and programming. Each of us contributed to a JIAS special issue entitled, “HIV epidemics among transgender populations: the importance of a trans‐inclusive response” in 2016 [2]. In this issue, editors noted, “It cannot be overstated that transgender women are not MSM and should not be subsumed in a category that erases their identity [3].” Four years later, this special issue fails to heed that call.

In 2016, Global Public Health published a series of articles describing the impact of conflating transgender women with MSM. In that issue, Poteat et al. outline issues that may be completely missed when transgender women are assumed to have the same HIV risks as MSM [4]. Perez‐Brumer et al. identify how inclusion of HIV prevalence data from transgender women with MSM, artificially increases the reported prevalence among MSM as it simultaneously renders the elevated prevalence among transgender women invisible [5]. Kaplan et al. write to the limitations of Eurocentric notions of gender/sexuality and the impact on our understanding of drivers of HIV [6]. Sevelius et al. provide concrete examples from qualitative research with transgender women of the impact of conflation and erasure as a barrier to PrEP uptake among transgender women [7].

As HIV researchers who focus on the needs of transgender women in sub‐Saharan Africa, we know that such research is possible and that data from studies focused on African transgender women exist. A cursory review of recent published literature and abstracts from CROI 2020 and AIDS 2020 readily identified several research studies focused on transgender women in Africa [8, 9, 10, 11]. Meaningful inclusion of any population that appears in the title of a special issue should be a requisite. We urge JIAS to resist publishing studies that subsume transgender women within MSM‐focused research. Instead, we encourage JIAS to support the publication of studies that provide transgender women with the specific attention they deserve.

COMPETING INTERESTS

All authors declare no conflicts of interest.

AUTHORS’ CONTRIBUTIONS

TCP conceived of the manuscript and generated the initial draft. LLAVM, JS and JK reviewed and edited the draft. All authors have read and approved the final manuscript.

AUTHORS’ INFORMATION

LLAVDM and JK are transgender community leaders who have engaged in research and advocacy to improve the health of transgender women for well over a decade. LLAVDM is based in South Africa where she leads an international organization for transgender women. JK is based in the United States where she worked in academic research and programme development for many years. Both LLAVDM and JK have generated original HIV research with transgender women as co‐principal investigators. TCP and JS have conducted community‐engaged research in partnership with transgender‐led organizations for more than a decade.

Poteat, T. C. , van der Merwe, L. L. A. , Sevelius, J. and Keatley, J. Inclusion as illusion: erasing transgender women in research with MSM. J Int AIDS Soc.2021; 24(1):e25661

REFERENCES

  • 1. Crowell TA, Fast PE, Bekker L‐G, Sanders EJ. Involvement of African men and transgender women who have sex with men in HIV research: progress, but much more must be done. J Int AIDS Soc. 2020;23:e25596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Poteat TC, Keatley J, Wilcher R, Schwenke C. (Eds.). HIV epidemics among transgender populations: the importance of a trans‐inclusive response [Special Issue]. J Int AIDS Soc. 2016;19(3S2). https://onlinelibrary.wiley.com/toc/17582652/2016/19/3S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Poteat TC, Keatley J, Wilcher R, Schwenke C. Evidence for action: a call for the global HIV response to address the needs of transgender populations. J Int AIDS Soc. 2016;19:21193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Poteat T, German D, Flynn C. The conflation of gender and sex: Gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016;11(7–8):835–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Perez‐Brumer AG, Oldenburg CE, Reisner SL, Clark JL, Parker RG. Towards ‘reflexive epidemiology’: conflation of cisgender male and transgender women sex workers and implications for global understandings of HIV prevalence. Glob Public Health. 2016;11(7–8):849–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kaplan RL, Sevelius J, Ribeiro K. In the name of brevity: the problem with binary HIV risk categories. Glob Public Health. 2016;11(7–8):824–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans‐specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. King R, Nanteza J, Sebyala Z, Bbaale J, Sande E, Poteat T, et al. HIV and transgender women in Kampala, Uganda‐Double Jeopardy. Cult Health Sex. 2019;21(6):727–40. [DOI] [PubMed] [Google Scholar]
  • 9. Poteat T, Malik M, van der Merwe LLA, Cloete A, Adams D, Nonyane BAS, et al. PrEP awareness and engagement among transgender women in South Africa: a cross‐sectional, mixed methods study. Lancet HIV. 2020;S2352–3018(20):30119–3. [DOI] [PubMed] [Google Scholar]
  • 10. Smith AD, Kabuti R, Irungu E, Nyamweya C, Fearon E, Weatherburn P, et al. The Burden of HIV and Other STIs among Transgender Persons in Nairobi, Kenya. Poster session presented at: Conference on Retroviruses and Opportunistic Infections; 2019 March 4‐7; Seattle, Washington.
  • 11. Personna MN, David‐Gnahoui B, Dioukhane E, Septime H, Sacko F, Kanoute AK, et al. HIV epidemiology and risk factors among transgender people in Mali. Poster session presented at: AIDS 2020: Virtual. 23rd International AIDS Conference; 2020 July 6–10; Virtual.

Articles from Journal of the International AIDS Society are provided here courtesy of Wiley

RESOURCES